Dr Walford asked Dr Fowler of Medicines Division whether the supply of blood comprising pre-March plasma could be resisted.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford